Erciyes University Hospital

Kayseri 38039

1 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Multiple Myeloma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed